Firm | Analyst | |
---|---|---|
Bank of America
|
Alec Stranahan | alec.stranahan@bofa.com |
Barclays
|
Gena Wang | gena.wang@barclays.com |
Bernstein
|
William Pickering | william.pickering@bernstein.com |
BMO Capital Markets
|
Kostas Biliouris | kostas.biliouris@bmo.com |
Brookline Capital Markets
|
Leah Cann | leah.cann@brooklinecapmkts.com |
Canaccord Genuity
|
Whitney Ijem | wijem@cgf.com |
Cantor Fitzgerald
|
Rick Bienkowski | rick.bienkowski@cantor.com |
Chardan Capital Markets
|
Geulah Livshits | glivshits@chardan.com |
Citi
|
David Lebowitz | david.lebowitz@citi.com |
Evercore ISI
|
Liisa Bayko | liisa.bayko@evercoreisi.com |
Goldman Sachs
|
Salveen Richter | salveen.richter@gs.com |
Guggenheim Partners
|
Debjit Chattopadhyay | debjit.chattopadhyay@guggenheimpartners.com |
Jefferies
|
Maury Raycroft | maury.raycroft@jefferies.com |
JMP Securities
|
Silvan Tuerkcan | stuerkcan@jmpsecurities.com |
Jones Research
|
Debanjana Chatterjee | dchatterjee@jonestrading.com |
J.P. Morgan
|
Brian Cheng | brian.cheng@jpmorgan.com |
Leerink Partners
|
Mani Foroohar | mani.foroohar@leerink.com |
Morgan Stanley
|
Terence Flynn | terence.flynn@morganstanley.com |
Oppenheimer & Co.
|
Jay Olson | jay.olson@opco.com |
Raymond James
|
Steven Seedhouse | steve.seedhouse@RaymondJames.com |
RBC
|
Luca Issi | luca.issi@rbccm.com |
Robert W. Baird & Co.
|
Jack Allen | jkallen@rwbaird.com |
Stifel
|
Dae Gon Ha | had@stifel.com |
TD Cowen
|
Joseph Thome | joseph.thome@cowen.com |
Truist
|
Joon Lee | joon.lee@truist.com |
Wedbush
|
David Nierengarten | david.nierengarten@wedbush.com |
Wells Fargo
|
Yanan Zhu | yanan.zhu@wellsfargo.com |
William Blair
|
Myles Minter | mminter@williamblair.com |
Wolfe Research
|
Andy Chen | achen@wolferesearch.com |
Intellia Therapeutics is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Intellia Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Intellia Therapeutics or its management. Intellia Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.